1. Home
  2. PLNT vs ABCL Comparison

PLNT vs ABCL Comparison

Compare PLNT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Fitness Inc.

PLNT

Planet Fitness Inc.

HOLD

Current Price

$41.98

Market Cap

3.9B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$13.74

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLNT
ABCL
Founded
1992
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PLNT
ABCL
Price
$41.98
$13.74
Analyst Decision
Buy
Strong Buy
Analyst Count
18
11
Target Price
★ $66.31
$16.70
AVG Volume (30 Days)
2.6M
★ 4.4M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 10.91
EPS
★ N/A
N/A
Revenue
★ $1,324,144,000.00
$75,128,000.00
Revenue This Year
$15.01
N/A
Revenue Next Year
$6.96
$7.91
P/E Ratio
$38.47
★ N/A
Revenue Growth
12.06
★ 160.56
52 Week Low
$37.03
$2.75
52 Week High
$114.26
$14.98

Technical Indicators

Market Signals
Indicator
PLNT
ABCL
Relative Strength Index (RSI) 35.19 63.52
Support Level $39.90 $10.38
Resistance Level $54.24 N/A
Average True Range (ATR) 2.23 0.77
MACD -0.35 0.08
Stochastic Oscillator 20.62 69.60

Price Performance

Historical Comparison
PLNT
ABCL

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: